Table 3 Anthropometric, clinical and metabolic characteristics according to rs1205

Age, years

55.4 ± 5.3

55.7 ± 5.7

0.596^a

Time since menopause, years

5 (2–10)

5 (2–12)

0.978^a

 WC < 88 cm

39.5% (73)

40.2% (53)

0.994^b

 WC ≥ 88 cm

60.5% (112)

59.8% (79)

  < 24.9

31.2% (39)

36.1% (69)

0.633^b

 25–30

44.8% (56)

42.9% (82)

  > 30

24.0% (30)

20.9% (40)

SBP, mmHg

125.9 ± 17.8

126.2 ± 18.7

0.902^a

DBP, mmHg

80.2 ± 11.5

79.7 ± 11.7

0.714^a

Total cholesterol, mg/dl

207.2 ± 46.1

210.5 ± 43.7

0.510^a

HDL-c, mg/dl

55.7 ± 12.7

58.8 ± 14.6

0.300^a

LDL-c, mg/dl

124.5 ± 40.2

127.5 ± 34.5

0.476^a

Triglycerides, mg/dl

140.7 ± 141.8

139.6 ± 118.2

0.938^a

Glucose, mg/dl

93.1 ± 18.3

94.2 ± 24.3

0.662^a

HOMA-IR

1.7 (1.3–2.3)

1.8 (1.2–2.7)

0.229^a

Insulin, μUI/ml

7.3 (5.7–9.8)

8.0 (5.6–11.6)

0.354^a

Metabolic syndrome, % (n)

31.8% (41)

28.1% (55)

0.552^b

hs-CRP, mg/l

2.1 (1.0–3.9)

1.5 (0.63–2.6)

0.004^a

IL6, pg/mL (n = 279)^c

1.13 (0.85–1.79)

1.13 (0.76–1.74)

0.285^a

HT, % (n)

28.7% (37)

29.3% (58)

0.999^b